A Blueprint to Address Research Gaps in the Development of Biomarkers for Pediatric Tuberculosis

Clinical Infectious Diseases

Volumn 61, Issue , 2015, Pages S164-S172

  Nicol, Mark Patrick ^a   Gnanashanmugam, Devasena ^b   Browning, Renee ^b   Click, Eleanor S ^c   Cuevas, Luis E ^d   Detjen, Anne ^e   Graham, Steve M ^e,f,g   Levin, Michael ^h   Makhene, Mamodikoe ^b   Nahid, Payam ⁱ   Perez Velez, Carlos M ^j   Reither, Klaus ^k   Song, Rinn ^l,m   Spiegel, Hans M L ^b   Worrell, Carol ^b   Zar, Heather J ⁿ   Walzl, Gerhard ^o  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^e INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

^f UNIVERSITY OF MELBOURNE   (Australia)

^g BURNET INSTITUTE   (Australia)

^h IMPERIAL COLLEGE LONDON   (United Kingdom)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j UNIVERSITY OF ARIZONA   (United States)

^k UNIVERSITY OF BASEL   (Switzerland)

^l BOSTON CHILDREN S HOSPITAL   (United States)

^m HARVARD MEDICAL SCHOOL   (United States)

ⁿ UNIVERSITY OF CAPE TOWN   (South Africa)

^o UNIVERSITY OF STELLENBOSCH   (South Africa)

more..

Author keywords

biomarker; blueprint; children; diagnosis; Tuberculosis

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; CHILD; CHILD NUTRITION; CHILDHOOD DISEASE; EXTRAPULMONARY TUBERCULOSIS; FOLLOW UP; HEALTH CARE DELIVERY; HUMAN; LATENT TUBERCULOSIS; LUNG TUBERCULOSIS; MICROORGANISM DETECTION; NATIONAL HEALTH ORGANIZATION; PEDIATRIC TUBERCULOSIS; PRIORITY JOURNAL; TREATMENT RESPONSE; TUBERCULOSIS; BIOBANK; CONSENSUS DEVELOPMENT; MEDICAL RESEARCH; PEDIATRICS; SPECIMEN HANDLING; UNITED STATES;

BIOLOGICAL SPECIMEN BANKS; BIOMARKERS; BIOMEDICAL RESEARCH; CHILD; DELIVERY OF HEALTH CARE; HUMANS; NATIONAL INSTITUTES OF HEALTH (U.S.); PEDIATRICS; SPECIMEN HANDLING; TUBERCULOSIS; UNITED STATES;

EID: 84943406528     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/civ613     Document Type: Article

References (32)

1. World Health Organization. Global tuberculosis report 2014. Geneva, Switzerland: WHO, 2014:1-289.
2. Dodd PJ, Gardiner E, Coghlan R, Seddon JA. Burden of childhood tuberculosis in 22 high-burden countries: a mathematical modelling study. Lancet Glob Health 2014; 2:e453-9.
3. Graham SM, Sismanidis C, Menzies HJ, Marais BJ, Detjen AK, Black RE. Importance of tuberculosis control to address child survival. Lancet 2014; 383:1605-7.
4. Swingler GH, du Toit G, Andronikou S, van der Merwe L, Zar HJ. Diagnostic accuracy of chest radiography in detecting mediastinal lymphadenopathy in suspected pulmonary tuberculosis. Arch Dis Child 2005; 90:1153-6.
5. HatherillM, HansloM, Hawkridge T, et al. Structured approaches for the screening and diagnosis of childhood tuberculosis in a high prevalence region of South Africa. Bull World Health Organ 2010; 88:312-20.
6. Marais BJ, Hesseling AC, Gie RP, Schaaf HS, Enarson DA, Beyers N. The bacteriologic yield in children with intrathoracic tuberculosis. Clin Infect Dis 2006; 42:e69-71.
7. Nicol MP,Workman L, IsaacsW, et al. Accuracy of the Xpert MTB/RIF test for the diagnosis of pulmonary tuberculosis in children admitted to hospital in Cape Town, South Africa: a descriptive study. Lancet Infect Dis 2011; 11:819-24.
8. Bates M, O'Grady J, Maeurer M, et al. Assessment of the Xpert MTB/RIF assay for diagnosis of tuberculosis with gastric lavage aspirates in children in sub-Saharan Africa: a prospective descriptive study. Lancet Infect Dis 2013; 13:36-42.
9. Rachow A, Clowes P, Saathoff E, et al. Increased and expedited case detection by Xpert MTB/RIF assay in childhood tuberculosis: a prospective cohort study. Clin Infect Dis 2012; 54:1388-96.
10. Pollock L, Basu Roy R, Kampmann B. How to use: interferon gamma release assays for tuberculosis. Arch Dis Child Educ Pract Ed 2013; 98:99-105.
11. World Health Organization. An international roadmap for tuberculosis research: towards a world free of tuberculosis. Geneva, Switzerland: WHO, 2011.
12. Murray CJ, Ortblad KF, Guinovart C, et al. Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014; 384:1005-70.
13. Pai M, Schito M. Tuberculosis diagnostics in 2015: landscape, priorities, needs, and prospects. J Infect Dis 2015; 211(suppl 2):S21-8.
14. Cepheid. Cepheid, FIND & Rutgers announce collaboration for nextgeneration innovations to game-changing Xpert MTB/RIF test, 2014. Available at: http://ir.cepheid.com/releasedetail.cfmreleaseid=878540. Accessed 14 February 2015.
15. Epistem. Genedrive products, 2015. Available at: http://www.genedrive. com/store/sales.phpproduct=3. Accessed 14 February 2015.
16. TrueLab. Truelab, 2015. Available at: http://www.molbiodiagnostics. com/molbiorealtime%20micro%20pcr%20system.html. Accessed 14 February 2015.
17. Petrucci R, Lombardi G, Corsini I, et al. Use of transrenal DNA for the diagnosis of extrapulmonary tuberculosis in children: a case of tubercular otitis media. J Clin Microbiol 2015; 53:336-8.
18. Botezatu I, Serdyuk O, Potapova G, et al. Genetic analysis of DNA excreted in urine: a new approach for detecting specific genomic DNA sequences from cells dying in an organism. Clin Chem 2000; 46(8 pt 1):1078-84.
19. Xie H, Mire J, Kong Y, et al. Rapid point-of-care detection of the tuberculosis pathogen using a BlaC-specific fluorogenic probe. Nat Chem 2012; 4:802-9.
20. Harapan H, Fitra F, Ichsan I, et al. The roles of microRNAs on tuberculosis infection: meaning or myth Tuberculosis 2013; 93:596-605.
21. Anderson ST, KaforouM, Brent AJ, et al. Diagnosis of childhood tuberculosis and host RNA expression in Africa. N Engl JMed 2014; 370:1712-23.
22. Portevin D, Moukambi F, Clowes P, et al. Assessment of the novel T-cell activation marker-tuberculosis assay for diagnosis of active tuberculosis in children: a prospective proof-of-concept study. Lancet Infect Dis 2014; 14:931-8.
23. Graham SM, Ahmed T, Amanullah F, et al. Evaluation of tuberculosis diagnostics in children: 1. Proposed clinical case definitions for classification of intrathoracic tuberculosis disease. Consensus from an expert panel. J Infect Dis 2012; 205(suppl 2):S199-208.
24. Graham SM, Cuevas LE, Jean-Philippe P, et al. Clinical case definitions for classification of intrathoracic tuberculosis in children: an update. Clin Infect Dis 2015; 61(suppl 3):S179-87.
25. Nicol MP, Allen V,Workman L, et al. Urine lipoarabinomannan testing for diagnosis of pulmonary tuberculosis in children: a prospective study. Lancet Glob Health 2014; 2:e278-84.
26. Zar HJ, Workman L, Isaacs W, et al. Rapid molecular diagnosis of pulmonary tuberculosis in children using nasopharyngeal specimens. Clin Infect Dis 2012; 55:1088-95.
27. Nicol MP, Spiers K, Workman L, et al. Xpert MTB/RIF testing of stool samples for the diagnosis of pulmonary tuberculosis in children. Clin Infect Dis 2013; 57:e18-21.
28. Walters E, Gie RP, Hesseling AC, Friedrich SO, Diacon AH, Gie RP. Rapid diagnosis of pediatric intrathoracic tuberculosis from stool samples using the Xpert MTB/RIF Assay: a pilot study. Pediatr Infect Dis J 2012; 31:1316.
29. Nahid P, Saukkonen J, Mac Kenzie WR, et al. CDC/NIH workshop. Tuberculosis biomarker and surrogate endpoint research roadmap. Am J Respir Crit Care Med 2011; 184:972-9.
30. Green C, Huggett JF, Talbot E,Mwaba P, Reither K, Zumla AI. Rapid diagnosisof tuberculosisthroughthedetectionofmycobacterialDNAinurine by nucleic acid amplification methods. Lancet Infect Dis 2009; 9:505-11.
31. ClinicalData Interchange Standards Consortium. CDISC: strength through collaboration. Available at: www.cdisc.org. Accessed 6 March 2015.
32. Vaught J, Rogers J, Myers K, et al. An NCI perspective on creating sustainable biospecimen resources. J Natl Cancer Inst Monogr 2011; 2011:1-7.